lymphoma: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.
| Name | CD2_IMMUNOPROLIFERATIVE |
|---|---|
| Long name | Malignant immunoproliferative diseases |
| Hospital Discharge registry | ICD-10: C88 |
| Cause of Death registry | ICD-10: C88 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF4 |
| Latin name | Morbi immunoproliferativi maligni |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 105 | 49 | 56 |
| Unadjusted prevalence (%) | 0.05 | 0.04 | 0.06 |
| Mean age at first event (years) | 64.97 | 65.68 | 64.35 |
| Case fatality at 5-years (%) | 13.33 | 16.33 | 10.71 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 3.0 | 2.0 | 5.0 |
| Recurrence at 6 months (%) | 57.14 | 48.98 | 64.29 |
before Malignant immunoproliferative diseases
after Malignant immunoproliferative diseases
Loading survival analyses plot…
Loading survival analyses table…